Cost-sharing requirements and access to mental health care among medicare enrollees with schizophrenia

Psychiatric Services

Volumn 56, Issue 8, 2005, Pages 960-966

  Slade, Eric P ^a   Salkever, David S ^b   Rosenheck, Robert ^c,d   Swanson, Jeffrey ^e   Swartz, Marvin ^e   Shern, David ^f   Gallucci, Gerard ^g   Harding, Courtenay ^h   Palmer, Liisa ⁱ   Russo, Patricia ^j  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d VA Northeast Program Evaluation Center   (United States)

^e DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF SOUTH FLORIDA   (United States)

^g JOHNS HOPKINS UNIVERSITY   (United States)

^h BOSTON UNIVERSITY   (United States)

ⁱ MEDSTAT GROUP   (United States)

^j NONE

more..

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; ARTICLE; FEMALE; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE MANAGEMENT; HEALTH CARE ORGANIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAID; MEDICARE; MENTAL HEALTH CARE; OUTPATIENT CARE; PSYCHIATRIST; SCHIZOPHRENIA;

ADULT; COST SHARING; FEMALE; HEALTH SERVICES ACCESSIBILITY; HUMANS; LOGISTIC MODELS; MALE; MEDICARE; MENTAL HEALTH SERVICES; MIDDLE AGED; SCHIZOPHRENIA; UNITED STATES;

EID: 23244432199     PISSN: 10752730     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ps.56.8.960     Document Type: Article

References (24)

1. Mental Health: A Report of the Surgeon General. Rockville, Md, Center for Mental Health Services, 1999
2. Lehman AF, Steinwachs DM: Primary Data Analysis: Schizophrenia Patient Outcomes Research Team. Washington, DC, Agency for Health Care Policy and Research, 1997
3. Mueser KT, Salyers MP, Mueser PR: A prospective analysis of work in schizophrenia. Schizophrenia Bulletin 27:281-296, 2001
4. Slade E, Salkever D: Symptom effects on employment in a structural model of mental illness and treatment: analysis of patients with schizophrenia. Journal of Mental Health Policy and Economics 4:25-34, 2001
5. Lohr K, Brook R, Kamberg C, et al: Effect of cost-sharing on use of medically effective and less effective care. Medical Care 24(suppl):S31-S38, 1986
6. Brian E, Gibbens S: California's Medi-Cal co-payment experiment. Medical Care 12(12 suppl):4-56, 1974
7. Nelson A, Reeder CE, Dickson WM: The effect of a Medicaid drug co-payment program on the utilization and cost of prescription services. Medical Care 22:724-736, 1984
8. Stuart B, Zacker C: Who bears the burden of Medieaid drug copayment policies? Health Affairs 18(2):201-212, 1999
9. Brook R, Ware J, Rogers W, et al: Does free care improve adults' health? Results from a randomized controlled trial. New England Journal of Medicine 309:1426-1434, 1983
10. Keeler E, Brook R, Goldberg G, et al: How free care reduced hypertension in the health insurance experiment. JAMA 254: 1926-1931, 1985
11. Lurie N, Kamberg C, Brook R, et al: How free care improved vision in the health insurance experiment. American Journal of Public Health 79:640-642, 1989
12. Lehman AF: Quality of care in mental health: the case of schizophrenia. Health Affairs 18(5):52-65, 1999
13. Dixon L, Lyles A, Smith C, et al: Use and costs of ambulatory care services among Medicare enrollees with schizophrenia. Psychiatric Services 52:786-792, 2001
14. Yanos PT, Crystal S, Kumar R, et al: Characteristics and service use patterns of nonelderly Medicare beneficiaries with schizophrenia. Psychiatric Services 52: 1644-1650, 2001
15. Fleishman M: Issues in psychopharmacosocioeconomics. Psychiatric Services 53:1532-1534, 2002
16. Clark RE, Ricketts SK, McHugo GJ: Measuring hospital use without claims: a comparison of patient and provider reports. Health Services Research 31:153-169, 1996
17. Kay SR, Fiszbein A, Opler LA: The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophrenia Bulletin 13:261-276, 1987
18. Montgomery SA, Asberg M: A new depression scale designed to be sensitive to change. British Journal of Psychiatry 134:382-389, 1979
19. Chan AW, Pristach EA, Weite JW: Detection by the CAGE of alcoholism or heavy drinking in primary care outpatients and the general population. Journal of Substance Abuse 6:123-135, 1994
20. Brown RL, Leonard T, Saunders LA, et al: The prevalence and detection of substance use disorders among inpatients ages 18 to 49: an opportunity for prevention. Preventive Medicine 27:101-110, 1998
21. Huber PJ: The behavior of maximum likelihood estimates under non-standard conditions, in Proceedings of the Fifth Berkeley Symposium on Mathematical Statistics and Probability. Berkeley, Calif, University of California Press, 1967
22. White H: Maximum likelihood estimation of misspecified models. Econometrica 50:1-25, 1982
23. Royall RM: Model robust confidence intervals using maximum likelihood estimators. International Statistical Review 54:221-226, 1986
24. Greenberg GA, Rosenheck RA: Continuity of care and clinical outcomes in a national health system. Psychiatric Services 56:427-423, 2005